Chen Fujiang, Guo Donglin, Zheng Tiantian, Gu Yangyang, Zhou Xinbin, Qiu Yuangang, Huang Shuwei, Ye Wenyi
Department of Anesthesiology, Shanxi Provincial People's Hospital, 030012 Taiyuan, Shanxi, China.
Department of Clinical Laboratory, Shanxi Provincial People's Hospital, 030012 Taiyuan, Shanxi, China.
Rev Cardiovasc Med. 2024 Jun 3;25(6):205. doi: 10.31083/j.rcm2506205. eCollection 2024 Jun.
Catheter ablation (CA) is an effective therapy for atrial fibrillation (AF) and, although radiofrequency ablation (RFA) is the standard treatment for pulmonary vein isolation (PVI), it is complex and time-consuming. Laser balloon ablation (LBA) has been introduced to simplify the conventional RFA; however, results of studies comparing LBA and RFA remain controversial. As such, this investigation aimed to comprehensively evaluate the efficacy and safety of LBA versus RFA.
The PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched for relevant studies. The primary endpoints were the freedom from atrial tachyarrhythmia (ATA) and procedure-related complications.
Twelve studies including 1274 subjects were included. LBA and RFA yielded similar rates of freedom from ATA (72.5% vs. 68.7%, odds ratio [OR] = 1.26, 95% confidence interval [CI] 1.0-1.7, = 0.11) and procedure-related complications (7.7% vs. 6.5%, OR = 1.17, 95% CI 0.72-1.90, = 0.536). LBA with the second- and third-generation laser balloons (LB2/3) yielded remarkably higher rates of freedom from ATA than RFA using contact-force technology (RFA-CF) (OR = 1.91, = 0.013). Significantly lower pulmonary vein (PV) reconnection rates (OR = 0.51, = 0.021), but higher phrenic nerve palsy (PNP) rates (OR = 3.42, = 0.023) were observed in the LBA group. LBA had comparable procedure (weighted mean difference [WMD] = 8.43 min, = 0.337) and fluoroscopy times (WMD = 3.09 min, = 0.174), but a longer ablation time (WMD = 12.57 min, = 0.00) than those for RFA.
LBA and RFA treatments were comparable in terms of freedom from ATA and postprocedural complications in patients with AF. Compared with RFA, LBA was associated with significantly lower PV reconnection rates, but a higher incidence of PNP and longer ablation time.
导管消融术(CA)是治疗心房颤动(AF)的有效方法,虽然射频消融术(RFA)是肺静脉隔离(PVI)的标准治疗方法,但它复杂且耗时。激光球囊消融术(LBA)已被引入以简化传统的RFA;然而,比较LBA和RFA的研究结果仍存在争议。因此,本研究旨在全面评估LBA与RFA的疗效和安全性。
检索PubMed、Embase、Cochrane图书馆和ClinicalTrials.gov数据库以获取相关研究。主要终点是无房性快速心律失常(ATA)和与手术相关的并发症。
纳入12项研究,共1274名受试者。LBA和RFA的无ATA率相似(72.5%对68.7%,优势比[OR]=1.26,95%置信区间[CI]1.0 - 1.7,P = 0.11),与手术相关的并发症发生率也相似(7.7%对6.5%,OR = 1.17,95%CI 0.72 - 1.90,P = 0.536)。使用第二代和第三代激光球囊(LB2/3)的LBA比使用接触力技术的RFA(RFA - CF)的无ATA率显著更高(OR = 1.91,P = 0.013)。LBA组的肺静脉(PV)重新连接率显著更低(OR = 0.51,P = 0.021),但膈神经麻痹(PNP)发生率更高(OR = 3.42,P = 0.023)。LBA的手术时间(加权平均差[WMD]=8.43分钟,P = 0.337)和透视时间(WMD = 3.09分钟,P = 0.174)与RFA相当,但消融时间更长(WMD = 12.57分钟,P = 0.00)。
在AF患者中,LBA和RFA治疗在无ATA和术后并发症方面具有可比性。与RFA相比,LBA的PV重新连接率显著更低,但PNP发生率更高,消融时间更长。